A recent Twitter exchange between billionaires Mark Cuban and Elon Musk may lead to employees paying less for prescriptions through Cuban's Cost Plus Drugs Co.
Peter Thiel, Mark Cuban and Warren Buffet funded early-stage startups and made millions. You don’t need to be a well-connected billionaire to do the same. Click here to invest in promising startups today.
Cuban founded the company with radiologist Alexander Oshmyansky to create a business that manufactures generic prescription drugs and sells them directly to consumers. The firm's goal is to cut out the local pharmacy from the prescription drug industry, treating it as an unnecessary middleman that pushes costs higher.
The company uses accredited pharmacists to fill prescriptions, review possible contradictions between medications and ensure patient safety. Cuban, the frequent investor and entrepreneur who is the biggest Shark on the reality TV show "Shark Tank," founded the company in response to frequent media stories about pharmaceutical price gouging and skyrocketing costs.
Healthcare businesses are becoming an increasingly vital part of the startup landscape. Medical debt negatively affects millions of Americans so solutions lowering costs can be life savers for those affected. Many startups continue to see success in this regard from telehealth solutions to startups like iRemedy, which created an AI procurement network for healthcare providers.
Doing Business Through Twitter
Musk became involved with talk about Cost Plus Drugs through a Twitter Inc. conversation. Twitter user Dr. Mary Talley Bowden asked Cuban why Cost Plus Drugs did not carry Ivermectin, the anti-parasite drug that was touted and debunked as a COVID-fighting drug. Cuban expressed interest in carrying the drug on the platform while finding a lower price, which is the company's core mission. During the Twitter exchange, Musk stated, "Good question" in response to the query about not carrying Ivermectin.
To stay updated with top startup news & investments, sign up for Benzinga's Startup Investing & Equity Crowdfunding Newsletter
Cuban responded by encouraging Musk to move Tesla and SpaceX employees to the CostPlus Drug program as a way to save them a tremendous amount of money. The combined companies employ around 140,000 people. Beyond the savings for employees, there is also the massive public relations win for Cuban and Cost Plus Drugs if Musk's companies hop on board. Musk has more than 144 million followers on Twitter, giving him a massive reach to consumers who need to purchase prescription drugs as well as fellow business leaders who listen intently to his messages and decisions. The Twitter exchange also brought the interest of Musk's sister Tosca Musk, who said her cinema streaming company Passionflix would also take a look at CostPlus Drug.
Combating Prescription Drug Markups
According to data on the Cost Plus Drugs website, there are substantial potential savings through the company's business model. For example, it says a 30-count supply of 400 mg of Imatinib, a drug used to fight leukemia costs $35.10 through Cost Plus Drugs, while it retails at $9,657.30 through other companies.
See more on startup investing from Benzinga.
- AI Startups Turn to Retail Investors To Fund the Growth of the $1.59 Trillion Artificial Intelligence Market
- Be An Owner, Not Just A Consumer: Retail Investors Are Taking Stakes In Their Favorite Startups To Own The Upside
Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.